TURNING POINT THERAPEUTICS

turning-point-therapeutics-logo

Turning Point Therapeutics is a clinical-stage structure-based drug design company for the discovery and development of precision medicines for cancer and other diseases. They focus on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating the tumor microenvironment and tumor immunity.
#SimilarOrganizations #People #Financial #Event #Website #More

TURNING POINT THERAPEUTICS

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2013-10-08

Address:
San Diego, California, United States

Country:
United States

Website Url:
http://www.tptherapeutics.com

Total Employee:
251+

Status:
Active

Contact:
(858)926-5251

Email Addresses:
[email protected]

Total Funding:
1.18 B USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Apache Microsoft Exchange Online Amazon


Similar Organizations

arkuda-therapeutics-logo

Arkuda Therapeutics

Arkuda Therapeutics is a pharmaceutical company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.


Current Advisors List

hongbo-lu_image

Hongbo Lu Board Member @ Turning Point Therapeutics
Board_member

j-jean-cui_image

J. Jean Cui Board Member @ Turning Point Therapeutics
Board_member
2013-11-01

jacob-chacko_image

Jacob Chacko Board Member @ Turning Point Therapeutics
Board_member
2018-11-01

sheila-gujrathi_image

Sheila Gujrathi Board Member @ Turning Point Therapeutics
Board_member
2017-12-01

athena-countouriotis_image

Athena Countouriotis Board Member @ Turning Point Therapeutics
Board_member

patrick-machado_image

Patrick Machado Board Member @ Turning Point Therapeutics
Board_member
2019-05-01

carl-l-gordon_image

Carl L. Gordon Board Member @ Turning Point Therapeutics
Board_member

simeon-george_image

Simeon George Board Member @ Turning Point Therapeutics
Board_member
2017-05-01

Current Employees Featured

kumar-srinivasan_image

Kumar Srinivasan
Kumar Srinivasan Executive Vice President & CBO @ Turning Point Therapeutics
Executive Vice President & CBO
2021-06-01

siegfried-reich_image

Siegfried Reich
Siegfried Reich Executive Vice President, CSO @ Turning Point Therapeutics
Executive Vice President, CSO
2020-03-01

j-jean-cui_image

J. Jean Cui
J. Jean Cui Scientific Founder & Board Member @ Turning Point Therapeutics
Scientific Founder & Board Member
2020-02-01

john-kc-lim_image

John K.C. Lim
John K.C. Lim Senior Vice President, Clinical Operations and Regulatory Affairs @ Turning Point Therapeutics
Senior Vice President, Clinical Operations and Regulatory Affairs

adam-d-levy_image

Adam D. Levy
Adam D. Levy Senior Vice President, Investor Relations and Corporate Communications @ Turning Point Therapeutics
Senior Vice President, Investor Relations and Corporate Communications
2021-11-01

athena-countouriotis_image

Athena Countouriotis
Athena Countouriotis President and Chief Executive Officer @ Turning Point Therapeutics
President and Chief Executive Officer
2018-05-01

mohammad-hirmand_image

Mohammad Hirmand
Mohammad Hirmand Executive Vice President & Chief Medical Officer @ Turning Point Therapeutics
Executive Vice President & Chief Medical Officer

steve-sabus_image

Steve Sabus
Steve Sabus Chief Commercial Officer @ Turning Point Therapeutics
Chief Commercial Officer
2022-05-01

homa-yeganegi_image

Homa Yeganegi
Homa Yeganegi Senior Vice President, Project Team Leader and Head of Medical Affairs @ Turning Point Therapeutics
Senior Vice President, Project Team Leader and Head of Medical Affairs
2020-01-06

jeffrey-p-whitten_image

Jeffrey P. Whitten
Jeffrey P. Whitten Vice President of Pre-Clinical Development @ Turning Point Therapeutics
Vice President of Pre-Clinical Development
2015-11-02

Founder


j-jean-cui_image

J. Jean Cui

y-peter-li_image

Y. Peter Li

Stock Details


Company's stock symbol is NASDAQ:TPTX

Investors List

lilly-asia-ventures_image

Lilly Asia Ventures

Lilly Asia Ventures investment in Private Equity Round - Turning Point Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Private Equity Round - Turning Point Therapeutics

foresite-capital_image

Foresite Capital

Foresite Capital investment in Private Equity Round - Turning Point Therapeutics

kenson-ventures_image

Kenson Ventures

Kenson Ventures investment in Private Equity Round - Turning Point Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Private Equity Round - Turning Point Therapeutics

venbio_image

venBio Partners

venBio Partners investment in Private Equity Round - Turning Point Therapeutics

nextech-invest_image

Nextech Invest

Nextech Invest investment in Private Equity Round - Turning Point Therapeutics

sr-one_image

SR One

SR One investment in Private Equity Round - Turning Point Therapeutics

orbimed-advisors_image

OrbiMed

OrbiMed investment in Private Equity Round - Turning Point Therapeutics

sr-one_image

SR One

SR One investment in Series C - Turning Point Therapeutics

Official Site Inspections

http://www.tptherapeutics.com Semrush global rank: 2.68 M Semrush visits lastest month: 6.26 K

  • Host name: 165.89.235.20
  • IP address: 165.89.235.20
  • Location: Trenton United States
  • Latitude: 40.2187
  • Longitude: -74.7404
  • Metro Code: 504
  • Timezone: America/New_York
  • Postal: 08629

Loading ...

More informations about "Turning Point Therapeutics" on Search Engine

Turning Point Therapeutics - Crunchbase Company Profile

Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases. Acquired by. Bristol-Myers Squibb. …See details»

Bristol Myers boosts cancer drug portfolio with $4.1 billion Turning ...

June 3 (Reuters) - Bristol Myers Squibb Co (BMY.N) said on Friday it will acquire drug developer Turning Point Therapeutics Inc (TPTX.O) for $4.1 billion in cash to help …See details»

Turning Point Therapeutics Granted Breakthrough Therapy …

SAN DIEGO, May 10, 2022 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a clinical-stage precision oncology company designing and …See details»

Bristol Myers Squibb Completes Acquisition of Turning Point

Aug 17, 2022 8:31am EDT. NEW YORK -- (BUSINESS WIRE)-- Bristol Myers Squibb (NYSE:BMY) announced today that it has successfully completed its acquisition of …See details»

Turning Point Therapeutics Announces Initial Clinical Data

SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies …See details»

Turning Point Therapeutics Granted Breakthrough Therapy

SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies …See details»

Turning Point Therapeutics Granted FDA Orphan Drug …

SAN DIEGO, June 17, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies …See details»

Turning Point Therapeutics acquired by Bristol Myers Squibb

Jun 3, 2022 Turning Point Therapeutics Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer …See details»

Turning Point Therapeutics Granted FDA Breakthrough Therapy

SAN DIEGO, Dec. 08, 2020 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies …See details»

Turning Point Therapeutics Announces Additional Details for …

SAN DIEGO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies …See details»

BMS to Acquire Turning Point Therapeutics in Deal Valued at $4.1B

Jun 3, 2022 Precision Oncology. BMS to Acquire Turning Point Therapeutics in Deal Valued at $4.1B. Jun 03, 2022 | staff reporter. Save for later. NEW YORK – Bristol Myers …See details»

Turning Point Therapeutics Company Profile - Office Locations

Turning Point Therapeutics $30.83 m in annual revenue in FY 2021. See insights on Turning Point Therapeutics including office locations, competitors, revenue, financials, …See details»

Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung …

Jan 10, 2024 Turning Point Therapeutics, a wholly owned subsidiary of Bristol Myers Squibb, sponsored and designed the trial with input from the investigators.See details»

Turning Point Therapeutics - Funding, Financials, Valuation

Turning Point Therapeutics has raised a total of. $1.2B. in funding over 8 rounds. Their latest funding was raised on Oct 26, 2020 from a Post-IPO Equity round. Turning Point …See details»

Organization | Turning Point Therapeutics - CDEK

Organization | Turning Point Therapeutics. Turning Point Therapeutics Report issue. For profit Phase 1 Phase 2. Founded: San Diego CA United States (2013) Status: …See details»

Turning Point Therapeutics Corporate Partnerships | CipherBio

Turning Point Therapeutics is a clinical-stage precision oncology company with a pipeline of internally discovered investigational drugs designed to address key limitations of …See details»

Home - Turning Point DVS

Welcome to Turning Point. Our mission is to assist survivors and their children in learning to overcome the cycle of physical, sexual, mental, and emotional abuse. We do this by …See details»

Turning Point Advocacy Services - GuideStar Profile

Mission. Turning Point provides safety, shelter, and stabilizing services for survivors of domestic and sexual violence. Ruling year info. 1995. Executive Director. Jolynn …See details»

Turning Point Advocacy Services | Warrenton, MO | Cause IQ

Jun 1, 2022 Description. Turning Point Advocacy Services provides shelter and services to victims of domestic violence and sexual assault with a mission to support survivors. …See details»

Charity Navigator - Rating for Turning Point Advocacy Services

Organization Mission. To provide shelter and services to victims of domestic violence and sexual assault. Rating Information. Great. This charity's score is 96%, earning it a Four …See details»

linkstock.net © 2022. All rights reserved